ITI (523610) Q2 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 24/25 earnings summary
29 Aug, 2025Executive summary
Unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2024 were approved by the Board on 14 November 2024.
The company continues to operate under a government-approved revival plan, with significant financial assistance received.
Financial highlights
Consolidated revenue from operations for H1 FY25 was ₹1,01,620 lakhs, up from ₹40,351 lakhs in H1 FY24.
Consolidated net loss for H1 FY25 stood at ₹16,164 lakhs, compared to a net loss of ₹22,882 lakhs in H1 FY24.
Standalone net loss for H1 FY25 was ₹16,119 lakhs, versus ₹22,840 lakhs in H1 FY24.
Basic and diluted EPS for H1 FY25 was (₹1.68) on both standalone and consolidated basis.
Outlook and guidance
Management asserts the going concern basis is appropriate, citing a high-value order book of ₹11,12,429 lakhs and additional orders of ₹29,104 lakhs.
Unbilled revenue of ₹1,81,115 lakhs is expected to be realized by completing contract milestones in the next 12 months.
Latest events from ITI
- Ongoing losses, audit disclaimer, and reliance on government support amid operational risks.523610
Q3 202613 Feb 2026 - Q1 FY25 saw continued losses and auditor disclaimers, but management cites a robust order book.523610
Q1 24/2524 Nov 2025 - Q2 FY26 saw continued losses and auditor disclaimers amid unresolved financial uncertainties.523610
Q2 25/2613 Nov 2025 - Net loss of ₹33,007 lakhs for nine months ended Dec 2024 amid auditor disclaimer and revival plan.523610
Q3 24/2529 Aug 2025 - Significant revenue growth offset by persistent losses and major audit concerns in FY25.523610
Q4 24/2529 Aug 2025 - Q1 FY26 saw continued losses, high expenses, and auditor disclaimer amid compliance and receivable issues.523610
Q1 25/2629 Aug 2025